Developing CAR T therapies for the treatment of oncological diseases

OneChain Immunotherapeutics is a clinical stage spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team. OneChain aims to develop CAR-T candidates as a treatment for oncological diseases.